Sastasundar Ventures Limited Approves Name Change to Health X Platform Limited and Business Expansion

Sastasundar Ventures Limited announced significant corporate restructuring plans following its Board of Directors meeting held on January 7, 2026. The board approved a comprehensive rebranding initiative that includes changing the company name to Health X Platform Limited and expanding its business scope through amendments to the Memorandum of Association.

Board Resolutions and Corporate Changes

The board meeting, which commenced at 3:30 PM and concluded at 4:00 PM, resulted in several key decisions that will reshape the company's identity and operational framework. The directors approved the alteration of the name clause from Sastasundar Ventures Limited to Health X Platform Limited, along with consequential changes to the company's Memorandum and Articles of Association.

Decision:	Details
Name Change:	Sastasundar Ventures Limited to Health X Platform Limited
Meeting Date:	January 7, 2026
Meeting Duration:	3:30 PM to 4:00 PM
Cut-off Date:	January 9, 2026
Approval Required:	Shareholders via Postal Ballot

Business Scope Expansion

The company plans to significantly expand its operational scope through amendments to the main object clause of its Memorandum of Association. Two new clauses will be inserted after the existing Clause 6 in the Main Object Clause, broadening the company's business activities into multiple sectors.

The first new clause authorizes the company to carry on healthcare, beauty care, personal care, pharmaceuticals, wellness, diagnostics, and food businesses. This includes manufacturing, processing, marketing, trading, distribution, and providing related services, either directly or through subsidiaries.

The second clause enables the company to design, develop, own, operate, manage, and maintain digital platforms and e-commerce services. This encompasses:

Marketplace operations and trading
Order fulfillment and warehousing
Logistics and data management
Analytics and consumer engagement
Digital marketing and promotion
All incidental and ancillary activities

Regulatory Approval Process

The proposed changes are subject to multiple levels of approval to ensure compliance with regulatory requirements. The board has authorized the dispatch of a postal ballot notice to shareholders, with the cut-off date for beneficial position (BENPOS) set for January 9, 2026.

Approval Stage:	Authority
Shareholder Approval:	Postal Ballot
Regulatory Approval:	Central Government
Registration:	Registrar of Companies
Additional Approvals:	Other concerned authorities

Compliance and Documentation

The board's decisions align with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, ensuring proper regulatory compliance for the proposed amendments. Company Secretary and Compliance Officer Pratap Singh has been authorized to manage the documentation and approval processes.

The comprehensive nature of these changes reflects the company's strategic vision to transform from its current business model into a diversified healthcare and digital platform entity. The rebranding to Health X Platform Limited signals the company's commitment to establishing a strong presence in the healthcare technology sector while maintaining its operational flexibility through subsidiary structures.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.28%	+8.93%	+4.25%	+12.99%	-0.46%	+164.02%

Sastasundar Ventures Limited promoter Banwari Lal Mittal has continued his pattern of increasing stake in the company through additional market purchases. The latest transaction, disclosed under SEBI regulations on December 31, 2025, represents the fifth set of acquisitions by the promoter in recent periods.

Latest Transaction Details

The most recent disclosure shows Mittal's continued investment in the company:

Parameter:	Details
Shares Acquired:	6,835 equity shares
Transaction Value:	₹20.61 lakh
Mode of Acquisition:	Market Purchase
Transaction Period:	December 17-29, 2025
Previous Shareholding:	33.74%
Updated Shareholding:	33.76%

Complete Transaction History

Mittal's shareholding has shown a steady increase through multiple market purchases:

Transaction Period:	Shares Acquired	Shareholding Before	Shareholding After
November 28 - December 1, 2025:	11,500 shares	33.63%	33.66%
December 2 - December 6, 2025:	10,280 shares	33.66%	33.69%
December 8 - December 9, 2025:	10,000 shares	33.69%	33.73%
December 11 - December 15, 2025:	3,406 shares	33.73%	33.74%
December 17 - December 29, 2025:	6,835 shares	33.74%	33.76%

The cumulative effect of these transactions has resulted in Mittal increasing his stake from 33.63% to 33.76%, representing a total acquisition of 42,021 equity shares across the five transaction periods.

Regulatory Compliance

In compliance with the Securities and Exchange Board of India (SEBI) regulations on insider trading, Sastasundar Ventures Limited has disclosed these transactions to the relevant authorities. The company filed the necessary disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The latest disclosure was signed by Pratap Singh, Company Secretary and Compliance Officer, and communicated to both BSE Limited and National Stock Exchange of India Limited on December 31, 2025.

This continued increase in stake by the promoter through market purchases demonstrates ongoing confidence in the company. The consistent pattern of acquisitions across multiple periods may be viewed as a notable development for stakeholders.